Search results for " downstream"

Article Your Reliable Downstream Bioprocessing. Our Proven AxiChrom Columns
The goal for biopharmaceutical manufacturers is to develop a process that will deliver material for clinical trials quickly and smoothly, achieve success in these trials, and scale up to commercial …

Poster Continuous chromatography in downstream processing of a monoclonal antibody
In this study, periodic counter current (PCC) chromatography and straight-through processing (STP) technologies were evaluated in a continuous three-step monclonal antibody (MAb) purification proces…

Webcast Find the Right Intensification Strategy for Your Upstream and Downstream Processes
Learn more from our process intensification experts on how to approach your upstream bioreactor operations and downstream capture in our free webinar.

Article Connected, Automated Downstream Process for mAb Screening and Evaluation
Click here to read more >> A pre-clinical lab is often faced with the need to constantly evaluate possible ways of increasing capacity and throughput. This study was done to show both proof of p…

Article Rapid Cycling Protein A-Based Fiber Chromatography to Address Emerging Downstream Bottlenecks
Fibro PrismA is a new protein A fiber chromatography format developed to complement traditional resin-based chromatography. The protein A fiber matrix has an open pore structure in which mass transf…

Downstream

Article Technology Innovations Improve Process Chromatography Performance
By Feliza Mirasol Selecting an appropriate separation technology for biologic manufacturing is a crucial task in maximizing productivity in downstream bioprocessing. Biomanufacturers consider se…

Article Unifying Continuous Biomanufacturing Operations
included the upstream and preliminary downstream steps of a monoclonal antibody (mAb) in 28 days, with the secondary downstream steps taking an additional two-and-a-half days (3). A 1998 analysis …

Article Continuous Manufacturing: A Changing Processing Paradigm
…Eric Langer, managing partner, BioPlan Associates—are manufactured through perfusion or continuous downstream processing, the field is evolving (1). Most of these processes are done piecewise, howeve…

Article The New World of Biopharmaceutical Manufacturing
Single-use technology has also precipitated changes in upstream and downstream processing.  Pharmaceutical Technology spoke with Eric Langer, managing partner at BioPlan Associates; John …

Previous PageNext Page